the pro forma says $3.5M in sh eq. - how long do they need to hold that to keep Nasdaq listing ? anyone ?
also the 10K says they can't do public offerings til sept 2017,
and only $1.8M in cash in a private offer, I don't think they will dilute till sept, if needed
on Rayva they seem to be taking their time, I bet Rayva is worth more money with the OPQ cleared up and an NDA submitted, cause that helps Rayva with an approval of DDAIP closer
also the patent issue OT raises is moot, DDAIP patnets only last till 2019,
still Apri did not give up their patent rights on anything they want to do, which is USA focused
it sounded like Pascoe said they are already working on the study for OPQ, so if they can resolve OPQ in Q2 and submit the NDA early in Q3, that is not so bad, an NDA decision in early Q1 2018 isn't too bad, and with a Rayva deal they might get enough cash to minimize dilution.
Market Data 
Markets 
